References
- Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid 1996;3:44–56.
- Ando Y, Ohlsson PI, Suhr O, Nyhlin N, Yamashita T, Holmgren G, Danielsson A, Sansgren O, Uchino M, Ando M. A new simple and rapid screening method for variant transthyretin-related amyloidosis. Biochem Biophys Res Commun 1996;228:480–483.
- Saito S, Ando Y, Nakamura M, Ueda M, Kim J, Ishima Y, Akaike T, Otagiri M. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis. Biochemistry 2005;44:11122–11129.
- Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 2008;582:1783–1787.
- Fiszman ML, Di Egidio M, Ricart KC, Repetto MG, Borodinsky LN, Llesuy SF, Saizar RD, Trigo PL, Riedstra S, Costa PP, Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1. Arch Neurol 2003;60:593–597.
- Milojevic J, Esposito V, Das R, Melacini G. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. J Am Chem Soc 2007;129:4282–4890.
- Bergström J, Engström U, Yamashita T, Ando Y, Westermark P. Surface exposed epitopes and structural heterogeneity of in vivo formed transthyretin amyloid fibrils. Biochem Biophys Res Commun 2006;348:532–539.
- Kim IG, Park SY, Oh TJ. Dithiothreitol induces the sacrificial antioxidant property of human serum albumin in a metal-catalyzed oxidation and gamma-irradiation system. Arch Biochem Biophys 2001;388:1–6.
- Otagiri M, Chuang VT. Pharmaceutically important pre- and posttranslational modifications on human serum albumin. Biol Pharm Bull 2009;32:527–534.